Skip to main content

NRX Pharmaceuticals, Inc.

NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001719406

No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding NRX Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of NRXP: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3834−4
Shares2.59M10.3M+7.67M (+295.7%)
Value$12.4M$25.1M+$12.7M (+102.8%)

New holders (8)

Institutions that held NRX Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to NRXP in Q1 2022
InstitutionSharesValue% of portfolio
Armistice Capital, LLC6,259,781$15.3M0.44%
Sabby Management, LLC782,473$1.92M0.82%
CVI Holdings, LLC625,978$1.53M0.10%
Renaissance Technologies LLC139,003$341.0K0.00%
United Asset Strategies, Inc.18,300$45.0K0.01%
Ursa Fund Management, LLC15,000$37.0K0.03%
Bank of New York Mellon Corp10,129$25.0K0.00%
Exchange Traded Concepts, LLC1,894$5.00K0.00%

Sold out (12)

Institutions that held NRX Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of NRXP in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Virtu Financial LLC61,583$294.0K
Jane Street Group, LLC53,732$257.0K
Squarepoint Ops LLC29,496$141.0K
Schonfeld Strategic Advisors LLC28,100$135.0K
Alpine Global Management, LLC25,326$121.0K
Engineers Gate Manager LP25,210$121.0K
Millennium Management LLC13,257$63.0K
Wealthcare Advisory Partners LLC13,000$62.0K
Raymond James Financial Services Advisors, Inc.11,567$55.0K
Marshall Wace, LLP2,499$12.0K
Psagot Value Holdings Ltd. / (Israel)2,000$10.0K
Quantbot Technologies LP1,700$8.00K